Wellington Management Group LLP Caribou Biosciences, Inc. Transaction History

Wellington Management Group LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.62 - $5.05 $131,939 - $411,292	81,444 Added 18.43%	523,250 $858,000
Q1 2024 May 15, 2024	BUY	$4.82 - $8.26 $2.13 Million - $3.65 Million	441,806 New	441,806 $2.27 Million
Q4 2023 Feb 12, 2024	BUY	$3.58 - $6.25 $1.12 Million - $1.96 Million	314,080 New	314,080 $1.8 Million
Q3 2023 Nov 14, 2023	BUY	$4.08 - $8.14 $812,348 - $1.62 Million	199,105 New	199,105 $951,000
Q1 2023 May 12, 2023	SELL	$4.3 - $7.78 $2,029 - $3,672	-472 Reduced 0.53%	89,224 $473,000
Q4 2022 Feb 13, 2023	BUY	$5.57 - $11.01 $499,606 - $987,552	89,696 New	89,696 $563,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.